TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00354822 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT03820921 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03820921 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT00005366 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00340496 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT03820141 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03820141 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02360787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02413190 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01171495 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00092612 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02023879 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03566160 — Predictive Biomarker (PRD): EED mRNA
Genes: EED
Study NCT03931863 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01153048 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03207997 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00999869 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00003433 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02369237 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02369237 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01595607 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03190746 — Predictive Biomarker (PRD): AS1 14-3-3 protein eta
Genes: YWHAH; YWHA1
Study NCT02516046 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00255125 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02831829 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02831829 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04035798 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT00084383 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00728793 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00728793 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04219007 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT04219007 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT04427371 — Predictive Biomarker (PRD): GSDMD mRNA
Genes: GSDMD; DFNA5L; GSDMDC1; FKSG10
Study NCT03117517 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03117517 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04540328 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT03125200 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04737382 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04348942 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00185042 — Predictive Biomarker (PRD): ACAT1 mRNA
Genes: ACAT1; ACAT; MAT
Study NCT04584151 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT01213329 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT02602184 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04303416 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT00814723 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01333241 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02080689 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03680560 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03555032 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01906541 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01906541 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03107780 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03107780 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT02694120 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT01212523 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01212523 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04336306 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03308201 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01353300 — Predictive Biomarker (PRD): DICER1 mRNA
Genes: DICER1; DICER; HERNA; KIAA0928
Study NCT02258256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03777774 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00957554 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04718571 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT01099137 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01805375 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01272674 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01492985 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03703115 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT03703115 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT03703115 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03703115 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00297583 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03408834 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04691713 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT03243604 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT04253223 — Predictive Biomarker (PRD): GCGR mRNA
Genes: GCGR
Study NCT02538081 — Safety Biomarker (SAF): DRD2
Study NCT03189706 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01805804 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT01805804 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study NCT03508999 — Surrogate Endpoint (SUR): Bacterial count
Study NCT00548223 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01582204 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT03979378 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT00487708 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT04232020 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT03729011 — Predictive Biomarker (PRD): CPB1 mRNA
Genes: CPB1; CPB; PCPB
Study NCT01563796 — Predictive Biomarker (PRD): DEK mRNA
Genes: DEK
Study NCT04028778 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00385710 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT00385710 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03398785 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03398785 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00871351 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01289041 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02088710 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00705289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04039685 — Predictive Biomarker (PRD): UCP1 mRNA
Genes: UCP1; SLC25A7; UCP
Study NCT03144947 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04026438 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT03636984 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04369287 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04369287 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study NCT04369287 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT02147470 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04544176 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01213043 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04162990 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04327258 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT04327258 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04712409 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00260260 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04486911 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01155830 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03987113 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT02100514 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04096521 — Predictive Biomarker (PRD): IGF2 mRNA
Genes: IGF2; PP1446
Study NCT02470559 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02470559 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02470559 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03617497 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03326544 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03326544 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04381819 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01033292 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT01054508 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02038881 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01431313 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT01431313 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02586311 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01052987 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02710487 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study NCT04811781 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02898220 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00365911 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00365911 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00365911 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02164214 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study NCT02164214 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02624609 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04560205 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04560205 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04560205 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04725084 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01468090 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT01437969 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT03396185 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01133522 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT02749227 — Predictive Biomarker (PRD): POMC mRNA
Genes: POMC
Study NCT02364583 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT01261884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01670396 — Predictive Biomarker (PRD): GNB3 mRNA
Genes: GNB3
Study NCT02158273 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00069940 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00107393 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04114851 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01083147 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00808691 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT01379534 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT04868175 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04539119 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01307891 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00064103 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01757860 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02022046 — Safety Biomarker (SAF): MTHFR
Study NCT01477359 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT00194259 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03062007 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02008903 — Predictive Biomarker (PRD): EBP mRNA
Genes: EBP
Study NCT02492490 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03652597 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02421900 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03837457 — Safety Biomarker (SAF): miR-155
Genes: MIR155
Study NCT01086761 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01086761 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03147560 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03224715 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03224715 — Predictive Biomarker (PRD): Protein patched homolog 1
Genes: PTCH1; PTCH
Study NCT05376046 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study NCT03405272 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00698906 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT01325207 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00313261 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04108325 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT02194309 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02154776 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02154776 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04177667 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03041077 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03670888 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00927147 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05132309 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02324257 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00173732 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT00238069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03680963 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03582033 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT04417621 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT02633995 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03459703 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT03459703 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02632786 — Surrogate Endpoint (SUR): Hematologic response
Study NCT04013503 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01884480 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00237484 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01588990 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT03154359 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00595829 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04580069 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00969345 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00340548 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03361163 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT01610570 — Predictive Biomarker (PRD): FLI1 mRNA
Genes: FLI1
Study NCT03203616 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00176033 — Predictive Biomarker (PRD): ABCC1 mRNA
Genes: ABCC1; MRP; MRP1
Study NCT00176033 — Predictive Biomarker (PRD): ABCC2 mRNA
Genes: ABCC2; CMOAT; CMOAT1; CMRP; MRP2
Study NCT00176033 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT05629949 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01500577 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT02365831 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03146338 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03146338 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00536510 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00536510 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02819674 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02321423 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT03573739 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01496040 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT03221634 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT02082860 — Predictive Biomarker (PRD): HMBS mRNA
Genes: HMBS; PBGD; UPS
Study NCT06392152 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study NCT01673984 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT04161807 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT01827735 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01827735 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03196024 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00318123 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06287008 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT04258163 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01484678 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01484678 — Predictive Biomarker (PRD): DMD
Genes: BMD; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272
Study NCT05140096 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02225561 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05075902 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04158752 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01566630 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02781987 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00362102 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03569085 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT02776865 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00532558 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03493607 — Predictive Biomarker (PRD): SHANK3 mRNA
Genes: SHANK3; KIAA1650; PROSAP2; PSAP2
Study NCT01234441 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02341040 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT01597401 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00003257 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02085265 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04090866 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01707628 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04324567 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study NCT04324567 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02356757 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02107170 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02107170 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04017936 — Safety Biomarker (SAF): Interleukin 1
Study NCT02493140 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03622723 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01300650 — Safety Biomarker (SAF): Interleukin 1
Study NCT01853787 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2